PD-L1 expression has been observed in several types of cancers, including melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma, and various forms of gastrointestinal cancers. The level of PD-L1 expression can vary significantly between different cancer types and even among patients with the same type of cancer.
